Recent randomized trials and CDC guidance support doxycycline postexposure prophylaxis as a targeted strategy to reduce bacterial STIs in high-risk populations.
Isabelle Lim, PharmD
Advertisement
Articles by Isabelle Lim, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves XFG-Adapted COVID-19 Vaccine, mRNA for the 2026-2027 Season
2
What Heidi Overton's FDA Nomination Could Mean for Pharmacy
3
FDA Approves First Oral Drug for Dermatomyositis
4
FDA Grants Fast Track Designation to Varsetatug Masetecan for Metastatic Colorectal Cancer
5